Related references
Note: Only part of the references are listed.Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Bo Angelin et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Cell Surface Low-Density Lipoprotein Receptor: Evidence for a Reciprocal Regulation
Hagai Tavori et al.
CIRCULATION (2013)
AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy: An Analysis From the LDL-C Assessment With Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined With Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 Trial
Nihar R. Desai et al.
CIRCULATION (2013)
Lipoprotein(a): resurrected by genetics
F. Kronenberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Common and Low-Frequency Genetic Variants in the PCSK9 Locus Influence Circulating PCSK9 Levels
Ekaterina Chernogubova et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Bo Angelin et al.
CELL METABOLISM (2012)
Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex
Ylva Bonde et al.
HEPATOLOGY (2012)
The PCSK9 decade
Gilles Lambert et al.
JOURNAL OF LIPID RESEARCH (2012)
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2011)
Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Haoyong Yu et al.
CLINICAL CHEMISTRY (2011)
Thyroid hormone action in metabolic regulation
Yiyun Song et al.
PROTEIN & CELL (2011)
Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans
Lena Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Lipid lowering with thyroid hormone and thyromimetics
Bo Angelin et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner
Andrew C. Adams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Paul W. Ladenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genetic and Metabolic Determinants of Plasma PCSK9 Levels
Susan G. Lakoski et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The thyromimetic T-0681 protects from atherosclerosis
Ivan Tancevski et al.
JOURNAL OF LIPID RESEARCH (2009)
Fifty years of advances in bile acid synthesis and metabolism
David W. Russell
JOURNAL OF LIPID RESEARCH (2009)
Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone
Cecilia Galman et al.
GASTROENTEROLOGY (2008)
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
T. Lundasen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin
KM Thelen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system
P Parini et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis
C Gälman et al.
GASTROENTEROLOGY (2005)
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice
L Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs
D Lütjohann et al.
STEROIDS (2004)
Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood
C Gälman et al.
JOURNAL OF LIPID RESEARCH (2003)
Thyroid hormone receptor β-deficient mice show complete loss of the normal cholesterol 7α-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol
H Gullberg et al.
MOLECULAR ENDOCRINOLOGY (2000)
The mechanism of action of thyroid hormones
JS Zhang et al.
ANNUAL REVIEW OF PHYSIOLOGY (2000)